It has now been established that the requirement for panretinal laser photocoagulation in proliferative diabetic retinopathy can be reduced by anti‐VEGF therapy (Writing Committee for the Diabetic Retinopathy Clinical Research et al. The gene discussed is VEGFA; the disease is diabetic retinopathy.